COPENHAGEN (AFX) - Chr Hansen Holding AS said the 8.2 bln dkr sale of Chr Hansen's ingredients business to PAI partners, completed today, is expected to lift net profit for the year by about 4.2 bln dkr.
Regarding its plan to distribute excess capital to shareholders following the 2004/05 annual accounts audit, Chr Hansen Holding said it will make an announcement about two weeks before the extraordinary dividend is paid out.
Following the sale, Chr Hansen Holding will be a pure pharmaceutical company in the area of allergy treatment through its subsidiary ALK-Abello AS.
As a consequence, Erik Soerensen, president and chief executive officer of the Chr Hansen group since 1995, will resign as of Aug 15.
Jens Bager, president and CEO of ALK-Abello AS, will replace Soerensen.
michael.delaine@afxnews.com
mdl/ma
COPYRIGHT
Copyright AFX News Limited 2005. All rights reserved.
The copying, republication or redistribution of AFX News content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
AFX News and the AFX Financial News logo are registered trademarks of AFX News Limited
For more information and to contact AFX: www.afxnews.com and www.afxpress.com
Regarding its plan to distribute excess capital to shareholders following the 2004/05 annual accounts audit, Chr Hansen Holding said it will make an announcement about two weeks before the extraordinary dividend is paid out.
Following the sale, Chr Hansen Holding will be a pure pharmaceutical company in the area of allergy treatment through its subsidiary ALK-Abello AS.
As a consequence, Erik Soerensen, president and chief executive officer of the Chr Hansen group since 1995, will resign as of Aug 15.
Jens Bager, president and CEO of ALK-Abello AS, will replace Soerensen.
michael.delaine@afxnews.com
mdl/ma
COPYRIGHT
Copyright AFX News Limited 2005. All rights reserved.
The copying, republication or redistribution of AFX News content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
AFX News and the AFX Financial News logo are registered trademarks of AFX News Limited
For more information and to contact AFX: www.afxnews.com and www.afxpress.com